Novavax, Inc. - Common Stock (NQ:NVAX)

11.71 +1.25 (+11.97%)

Delayed Quote Updated: 1:46 PM EDT, Oct 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Novavax, Inc. - Common Stock

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

68 69 Next >

5 Investors Still Betting Big on Novavax (NVAX) Stock ↗

March 01, 2023

NVAX stock is plummeting lower today after the biotechnology company reported fourth-quarter earnings and a issued going concern warning.

Via InvestorPlace

Jim Cramer Says He's Known Novavax Is 'Worthless' For 'Very Long Time,' Trashes Company For Being Too 'Promotional' ↗

March 01, 2023

Novavax Inc (NASDAQ: NVAX) shares are crashing Wednesday after the company warned that substantial doubt exists regarding its ability to continue. Jim Cramer isn't surprised.

Via Benzinga

Why Novavax Shares Are Trading Lower By Around 28%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Why Novavax Stock Is Crashing Today ↗

March 01, 2023

The vaccine maker gave a warning that no investor wants to hear.

Via The Motley Fool

Novavax Stock Down On Concern Over Whether The Company Can Continue ↗

February 28, 2023

Novavax warns that it may not be able to continue as a company.

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

March 01, 2023

Via Benzinga

NVAX Stock Alert: Is Novavax Going Bankrupt? ↗

March 01, 2023

NVAX stock is tanking after the pharma company said it might not be able to continue operations as sales of its Covid-19 vaccine are weak.

Via InvestorPlace

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2023 ↗

March 01, 2023

Via Benzinga

Here's The Good News For Novavax Ahead Of Its Fourth-Quarter Report ↗

February 28, 2023

Novavax is expected to report strong sales growth. But 2023 guidance will be key.

Via Investor's Business Daily

Earnings Preview: Novavax ↗

February 27, 2023

Via Benzinga

Why Novavax Stock Wilted on Wednesday ↗

February 22, 2023

It doesn't seem like investors are looking forward to the company's fourth-quarter and full-year 2022 earnings release.

Via The Motley Fool

Why Is Sarepta Therapeutics (SRPT) Stock Up 21% Today? ↗

March 01, 2023

Sarepta Therapeutics (SRPT) stock is heading higher on Wednesday following the release of its latest earnings report and an upgrade.

Via InvestorPlace

Why Is Helbiz (HLBZ) Stock Up 37% Today? ↗

March 01, 2023

Helbiz (HLBZ) stock is on the move Wednesday despite a lack of hard news concerning the electric bike and scooter company.

Via InvestorPlace

XPEV Stock Alert: What to Know as Xpeng Reports February Vehicle Deliveries ↗

March 01, 2023

Xpeng (XPEV) stock is worth checking on Wednesday after the electric vehicle (EV) company released delivery data for February.

Via InvestorPlace

Why Is Novavax (NVAX) Stock Down 26% Today? ↗

March 01, 2023

Novavax (NVAX) stock is dropping on Wednesday after the vaccine company warned investors about the state of its business.

Via InvestorPlace

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 01, 2023

Via Benzinga

Why Reata Pharmaceuticals Shares Are Trading Higher By 140%; Here Are 20 Stocks Moving Premarket ↗

March 01, 2023

Gainers Reata Pharmaceuticals Inc (NASDAQ: RETA) rose 140.8% to $75.06 in pre-market trading after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

March 01, 2023

It's time to start the day with another breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!

Via InvestorPlace

Resilient Stocks Look To Break Free As Nasdaq, S&P 500 Futures Climb: Brace For More Volatility, Sideways Movement Near Term, Says Analyst ↗

March 01, 2023

Stocks could attempt to return to their winning ways on Wednesday following the lackluster performance in the previous session. Mixed earnings news flow could, however, act as a dampener. Cues From...

Via Benzinga

Novavax, AMC Entertainment And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

March 01, 2023

U.S. stock futures traded higher this morning. Here are some big stocks recording losses in today’s pre-market trading session.

Via Benzinga

Tesla, Apple, AMC, Novavax, Rivian: Why These 5 Stocks Are Drawing Investors' Attention Today ↗

February 28, 2023

Via Benzinga

Rivian's Slamming on the Brakes, but This Vaccine Stock Is Falling Harder ↗

February 28, 2023

A couple of high-profile companies posted big declines in after-hours trading on Tuesday.

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

February 28, 2023

Via Benzinga

After-Hours Alert: Why Novavax Stock Is Plunging ↗

February 28, 2023

Novavax Inc (NASDAQ: NVAX) shares are tanking in Tuesday's after-hours session after the company reported weak fourth-quarter re

Via Benzinga

2 Stocks to Sell or Remove From Your Watchlist in 2023 ↗

February 28, 2023

Both stocks soared during the coronavirus vaccine race, but their time has passed.

Via The Motley Fool

Coronavirus Vaccine Market To Surpass $95 Billion By 2028

February 28, 2023

EQNX::TICKER_START (NASDAQ:SBFM),(NASDAQ:MRNA),(NASDAQ:NVAX),(NASDAQ:VIR),(NASDAQ:INO) EQNX::TICKER_END

Via FinancialNewsMedia

Nasdaq, S&P 500 Futures Flatline Ahead Of Housing, Consumer Data: Analyst Pins Hopes On Dollar, Fed Rates To Keep Flickering Rally Hopes Alive ↗

February 28, 2023

Trading in the U.S. index futures suggests stocks may start Tuesday’s session slightly higher, although the mood could be cautious ahead of some key economic data on the housing market, business...

Via Benzinga

Earnings Scheduled For February 28, 2023 ↗

February 28, 2023

Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter.

Via Benzinga

3 Supercharged Growth Stocks Down 89% to 97% That Billionaires Can't Stop Buying ↗

February 23, 2023

Beaten-down growth stocks were popular buys during the fourth quarter for some of the brightest billionaire money managers.

Via The Motley Fool

2 Beaten-Down Stocks That Might Be too Cheap to Ignore ↗

February 22, 2023

There is an argument for hitting the buy button, but it's important to consider the potential risks too.

Via The Motley Fool

< Previous 1 2

...

21 22 23 24 25 26 27 28 29

...

68 69 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.